Diagnostic Catheters Market Is Flourished At A CAGR Of Around 5.3% By 2031

A fresh prediction from Fact.The revenue from diagnostic catheters is expected to nearly quadruple by 2031, hitting US$ 6 Bn at a 10-year compound annual growth rate (CAGR) of more than 6%, according to MR, a provider of market research and competitive intelligence. Numerous reasons, including the rising incidence of chronic diseases, the ageing population, the increased desire for less invasive operations, and the growth in kidney and cardiovascular diseases, are driving the global market for diagnostic catheters.

The offer in this section includes a variety of opportunities, such as the ability to manufacture goods and provide retail, wholesale, and exhibiting services. The researchers at Fact.MR have used extensive rounds of both necessary and optional research to arrive at various estimations and projections for the demand for diagnostic catheters on both a global and regional scale.

𝗗𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝗮 𝗦𝗮𝗺𝗽𝗹𝗲 𝗖𝗼𝗽𝘆 𝗼𝗳 𝗧𝗵𝗶𝘀 𝗥𝗲𝗽𝗼𝗿𝘁: -https://www.factmr.com/connectus/sample?flag=S&rep_id=6866?PJ

Diagnostic catheters are a crucial component of minimally invasive procedures, offering a less invasive alternative to traditional surgical approaches for diagnosing and treating various medical conditions. These catheters are commonly used in cardiology, electrophysiology, neurology, gastroenterology, and urology. Diagnostic catheters come in a variety of types, including angiographic catheters, electrophysiology catheters, endoscopic catheters, and more. The market's performance is closely tied to advancements in medical technology, increasing prevalence of chronic diseases, and the rising demand for minimally invasive procedures.

𝗠𝗮𝗿𝗸𝗲𝘁 𝗣𝗹𝗮𝘆𝗲𝗿𝘀: -

Terumo Corporation
St. Jude Medical
Boston Scientific Corporation
Koninklijke Philips N.V.
C. R. Bard
Johnson & Johnson
Medtronic
Edward Lifesciences Corporation
B. Braun Melsungen AG
Cardinal Health

𝗖𝘂𝗿𝗿𝗲𝗻𝘁 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝗧𝗿𝗲𝗻𝗱𝘀:

Minimally Invasive Procedures: The diagnostic catheters market is seeing a surge in demand due to the rising popularity of minimally invasive procedures. Patients and healthcare providers prefer these procedures as they generally involve smaller incisions, reduced recovery times, and fewer complications.

Integration of Imaging Technologies: There is a growing trend in the integration of advanced imaging technologies, such as fluoroscopy, intravascular ultrasound (IVUS), and optical coherence tomography (OCT), into diagnostic catheters. These technologies provide real-time, high-quality images that aid in more precise diagnosis and treatment.

Navigation and Mapping Systems: The industry is witnessing increased adoption of navigation and mapping systems that enable precise catheter placement and real-time visualization during procedures. This technology is particularly prominent in cardiology and electrophysiology.

Cardiovascular Interventions: With the rising prevalence of cardiovascular diseases, there is a heightened demand for diagnostic catheters in cardiology. These catheters are used for angiography, coronary interventions, and electrophysiology studies.

Patient-Centric Approach: A notable trend is the development of patient-centric diagnostic catheters. This includes designing catheters that are more comfortable and less invasive for patients, as well as enhancing the user experience for healthcare providers.

𝗖𝗼𝗺𝗽𝗲𝘁𝗶𝘁𝗶𝘃𝗲 𝗟𝗮𝗻𝗱𝘀𝗰𝗮𝗽𝗲

The global market is a highly competitive. Competitiveness is mostly based on technological differentiation of various products offered by major market players in the diagnostic catheters market.

Technological aspects of products and brand loyalty are key criteria of consideration for buyers. These factors have boosted innovation in the industry and intensified rivalry among players.

Amid intense competition in the market, major market players are increasingly focusing on expanding their geographic presence into the high-growth emerging markets and strengthening their technological competitiveness in the market by acquiring smaller players that have the desired technological capabilities or geographic presence.

𝗦𝗼𝗺𝗲 𝗼𝗳 𝘁𝗵𝗲 𝗸𝗲𝘆 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁𝘀 𝗮𝗿𝗲:

In October 2015, Cardinal Health, Inc. acquired Johnson & Johnson's (U.S.) Cordis business, a global player in the cardiovascular and endovascular devices market. The acquisition enhanced Cardinal Health's portfolio of diagnostic catheters used in cardiology and endovascular applications, helping Cardinal Health to strengthen its position in the global market, specifically in the cardiovascular area.

In February 2015, Royal Philips (U.S.), a part of Koninklijke Philips N.V., acquired Volcano Corporation (U.S.), a global leader in intravascular imaging for coronary and peripheral therapeutic devices. This acquisition has helped the company to become a leading systems integrator in the fast-growing image-guided MIS market.

In October 2013, St. Jude Medical launched OCT-assisted system for coronary imaging in the U.S. This system uses St. Jude's Dragonfly Duo Imaging catheter to capture near-infrared light. This launch has enhanced the company's portfolio for advanced diagnostic catheters in the US market.

𝗞𝗲𝘆 𝗦𝗲𝗴𝗺𝗲𝗻𝘁𝘀 𝗖𝗼𝘃𝗲𝗿𝗲𝗱 𝗶𝗻 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰 𝗖𝗮𝘁𝗵𝗲𝘁𝗲𝗿𝘀 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵

𝗕𝘆 𝗣𝗿𝗼𝗱𝘂𝗰𝘁
Diagnostic Imaging Catheters
Diagnostic Ultrasound Catheters
Diagnostic Angiography Catheters
Diagnostic Electrophysiology Catheters
Diagnostic OCT Catheters
Diagnostic Non-imaging Catheters
Temperature Monitoring Catheters
Pressure & Hemodynamic Monitoring Catheters

𝗕𝘆 𝗔𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻
Diagnostic Catheters in Cardiology
Diagnostic Catheters in Urology
Diagnostic Catheters in Neurology
Diagnostic Catheters in Gastroenterology

𝗥𝗲𝗴𝗶𝗼𝗻𝗮𝗹 𝗮𝗻𝗮𝗹𝘆𝘀𝗶𝘀 𝗶𝗻𝗰𝗹𝘂𝗱𝗲𝘀

North America (U.S., Canada)
Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
EU - (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
CIS & Russia
Japan
Asia Pacific Excluding Japan (Greater China, India, S. Korea, ASEAN Countries, Rest of APEJ)

𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝗡𝗲𝘄𝘀:

several noteworthy developments and news items were shaping the diagnostic catheters market:

Technological Advancements: Leading medical device manufacturers were investing in research and development to enhance the capabilities of diagnostic catheters. This included the development of catheters with improved imaging and navigation features.

Artificial Intelligence (AI) Integration: AI is being integrated into diagnostic catheter systems to assist in real-time decision-making during procedures. AI can analyze data from imaging technologies and provide insights to guide healthcare providers.

Telemedicine and Remote Procedures: The COVID-19 pandemic accelerated the adoption of telemedicine and remote procedures. Diagnostic catheter procedures were being performed remotely with the assistance of advanced technologies and robotic systems.

FDA Approvals: Various diagnostic catheters and associated technologies received approvals from regulatory bodies, indicating their safety and efficacy for clinical use. These approvals were essential for expanding the market.

Market Consolidation: The diagnostic catheters market witnessed a degree of consolidation, with mergers and acquisitions aimed at strengthening the product portfolios of medical device companies and expanding their global presence.

𝗖𝘂𝘀𝘁𝗼𝗺𝗶𝘇𝗲 𝘁𝗵𝗶𝘀 𝗿𝗲𝗽𝗼𝗿𝘁 𝗳𝗼𝗿 𝘆𝗼𝘂𝗿 𝘀𝗽𝗲𝗰𝗶𝗳𝗶𝗰 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝘀𝗼𝗹𝘂𝘁𝗶𝗼𝗻:https://www.factmr.com/connectus/sample?flag=RC&rep_id=6866?PJ

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E Mail : sales@factmr.com

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range - from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories.

This release was published on openPR.